Sanoculis
Latest round
- Series C
Last raised
- Jan 2023
Total raised
- Undisclosed
Investors
- 2
About Sanoculis
a. Sanoculis operates as an ophthalmic medical equipment company that manufactures devices for the treatment of eye diseases, particularly the minimally invasive micro sclerotomy for glaucoma. In January 2023, Sanoculis Ltd. The company’s product line includes MIMS, a lightweight surgical system intended for use by professional ophthalmologists that creates a drainage channel to reduce IOP in glaucoma patients, ensuring a long-lasting safe, and controlled fluid flow, no stitches, eye-patch, implant, or stent.
Who invested in Sanoculis
2 investors across 1 round
See all investors in Sanoculis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 25, 2023
Amount
Undisclosed
Investors
Questions about Sanoculis
Who invested in Sanoculis?
Sanoculis has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sanoculis raised?
Sanoculis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sanoculis last raise money?
Sanoculis's most recent round on record is a Series C, in Jan 2023.
What does Sanoculis do?
Sanoculis is a medical devices & equipment company.
Where is Sanoculis headquartered?
Sanoculis is headquartered in Kiryat Ono, Israel.
Which VCs invest in companies like Sanoculis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Sanoculis's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Sanoculis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.